ResearcherUniversity of MissouriActive in the last 2 years

Olamide Tosin Olaoba

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3620-4876; OpenAlex author ID A5070197263. Sources: OpenAlex.

Their work

Papers: 4 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 4

Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. First author DOI 10.1016/j.omton.2025.201080 ↗
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16081470 ↗
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. Co-author DOI 10.3390/cancers16101808 ↗
Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. Co-author DOI 10.1016/j.bbcan.2020.188483 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eric T. Kimchi · 3 shared papers, 2024–2025 · strength 0.72
Guangfu Li · 3 shared papers, 2024–2025 · strength 0.72
Ming Jun Yang · 2 shared papers, 2024 · strength 0.48
- Paper Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers16081470 ↗
- Paper Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. DOI 10.3390/cancers16101808 ↗
Ernest Ramsay Camp · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Nan Lyu · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Xinjian Liu · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Yi Miao · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Kun Cheng · 1 shared paper, 2025 · strength 0.24
- Paper Mechanistic and functional characterization of ABTB2 as a novel target for pancreatic cancer therapy. DOI 10.1016/j.omton.2025.201080 ↗
Kehinde Sulaimon Ayinde · 1 shared paper, 2021 · strength 0.17
- Paper Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. DOI 10.1016/j.bbcan.2020.188483 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.